◆ 会议时间：2026年9月5-9日
◆ 会议地点：西班牙 巴塞罗那


◆ 会议简介：

2026年第36届欧洲呼吸学会(ERS)大会/年会将于2026年9月5-9日在西班牙巴塞罗那举行举行。

欧洲呼吸学会(ERS)年会/大会是世界上最大的呼吸医学专业学术会议，届时世界各地的呼吸系统专家汇聚一堂，介绍并讨论整个呼吸医学领域的最新科学和临床研究进展。欧洲呼吸学会(ERS)年会拥有杰出的科学教育计划，以满足研究人员、临床医生、全科医生和专职卫生专业人员的需求。与每年一样，欧洲呼吸年会将涵盖14个科学领域的呼吸医学关键议题，其中包括结核病、肺癌、慢性和急性呼吸衰竭、睡眠呼吸障碍、间质性肺病、肺炎、囊性纤维化、COPD和哮喘等；预计将有超过2万名来自世界各地的呼吸医学及宣相关领域的专业人士注册参会；2024年ERS大会有19913名代表参与。

欧洲呼吸学会（ERS）是呼吸领域领先的医疗机构之一，是一个汇集了医生、医疗保健专业人士、科学家和其他呼吸领域医学专家的国际组织，ERS会员来自全球160多个国家。ERS的使命是促进肺部健康，减轻疾病的痛苦并推动在全球范围内制定呼吸医学标准。——未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com)。

ERS Congress 2026 - European Respiratory Society (ERS) Congress

Date:
5 - 9 September, 2026

Venue:
Fira Gran Via (North Access)
Barcelona, Spain

Our annual congress is the once-a-year occasion when the world’s respiratory experts meet, to present and discuss the latest scientific and clinical advances across the entire field of respiratory medicine. The reputation of ERS derives from the outstanding scientific programme of our congress, which is now the largest respiratory meeting in the world.

摘要与临床病例征文投稿：

Call for Abstracts and clinical cases

Call for abstracts/clinical cases

The deadline to submit is 5 February 2026 at 23:59 CET.

点此提交>>>Submit now

View priority topics for the ERS Congress 2026.

Abstracts

Abstract submission (first round) for the ERS Congress 2026 (5-9 September in Barcelona, Spain) is open. The deadline to submit is 5 February 2026 at 23:59 CET.

Submitting abstracts for the ERS Congress offers researchers the chance to share their preliminary findings at the world’s largest respiratory meeting, helping to boost research as it progresses and enabling the exchange of the latest findings in respiratory medicine and science. All Congress abstracts are also published online in a supplement of the European Respiratory Journal.

Check the ERS guidelines and instructions for submitting abstracts.

How to write an abstract: Breathe article.

Find out more about abstracts on our frequently asked questions page.

Calls for abstracts in 2026

There will be three opportunities to submit abstracts for the upcoming ERS Congress:

How to submit abstracts

Once the submission is open, all abstracts must be submitted online through myERS, allowing authors to review, edit and submit abstracts from one easy-to-access platform. Abstracts sent by email will not be considered.

If you already have a myERS account, you will be able to sign in and start the submission process. Navigate to ‘Abstracts/Cases’, then ‘Congress’ and then ‘Access Abstracts Platform’ to get started.

If you do not have a myERS account, you can create an account for free. ERS membership is not required.

The recommended web browsers for accessing the submission platform are Google Chrome and Mozilla Firefox.

Authors who have applied for grants and sponsorship must ensure that they are listed as the corresponding author of the abstract. Please note that this information will be sent to the corresponding authors only.

Review and programme allocation

All abstracts are peer-reviewed for quality and suitability for the congress programme.

If accepted, the Congress Programme Committee will allocate successful abstracts to a variety of session types, including:

• Oral presentations
• Poster sessions
• Clinical trial sessions

Clinical cases

Clinical case submission for the ERS Congress 2026 (5–9 September in Barcelona, Spain) is open. The deadline to submit is 5 February 2026 at 23:59 CET.

Why submit clinical cases?

ERS encourages the respiratory community to submit interesting clinical cases for the ERS Congress. This is a great opportunity to share your experiences, have cases presented in front of key opinion leaders in the field and actively contribute to the largest meeting in the respiratory calendar. Submitted cases may also be considered for presentation in other ERS events/activities taking place throughout the year.

Check the guidelines and instructions for submitting clinical cases

How to submit clinical cases

All clinical cases are submitted online through myERS, allowing contributors to review, edit and submit cases from one easy-to-access platform.

You may submit up to three cases per disease area, including:

• Airway diseases
• Interstitial lung diseases
• Paediatric respiratory diseases
• Pulmonary vascular diseases
• Respiratory critical care
• Respiratory infections
• Sleep and breathing disorders
• Thoracic oncology

When preparing cases for submission, please structure submissions under the following sections:

1. Case history
2. Investigations
3. Results and treatment
4. Conclusions and points for discussion

Once submission is open, you can submit your clinical case via myERS. Navigate to ‘Abstracts/Cases’, then ‘Congress’ and then ‘Access Clinical Cases Platform’ to get started.

If you do not have a myERS account, you can create an account for free. ERS membership is not required.

The recommended web browsers for accessing the submission platform are Google Chrome and Mozilla Firefox.

Review and programme allocation

All submitted clinical cases are reviewed for quality and suitability.

If accepted for Congress, the Congress Programme Committee and case-based session experts will allocate cases to the following session type:

• Lungs on Fire

Submitted cases may also be used as part of ERS’s wider educational activities outside of the Congress.

Notification of selection

Case submitters will be notified about the outcome of their submission(s) in early June.

Submitters (main authors) of accepted cases must be present in person in Barcelona to participate in the on-stage discussion with the panel of experts during their case presentation by a discussant in Lungs on Fire session. If they are unable to attend onsite, they may nominate a co-author to participate on their behalf. Additional details will be provided along with the notification of results.

Co-authors’ participation at the ERS Congress is encouraged, but not obligatory. 

ERS Congress 2026: Barcelona
ERS 2026-欧洲呼吸年会-ERS欧洲呼吸年会-ERS国际大会-2026ERS年会-欧洲呼吸学会年会-巴塞罗那

◆ 参会对象：
呼吸科医生，外科医生，重症监护医生，护士，医院管理者、呼吸科主任、副主任、医生及从事该领域研究的专家、科研人员、医药企业等。